Detalles de la búsqueda
1.
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Int J Mol Sci
; 25(5)2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473737
2.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 266-274, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396818
3.
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.
BMC Cancer
; 22(1): 623, 2022 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672679
4.
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience.
Future Oncol
; 18(24): 2651-2659, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35791815
5.
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review.
Int J Mol Sci
; 23(13)2022 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35806079
6.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152285
7.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330065
8.
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials.
BMC Cancer
; 20(1): 418, 2020 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404154
9.
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.
Oncologist
; 24(6): 743-e205, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30591548
10.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747948
11.
Immune characterization of breast cancer metastases: prognostic implications.
Breast Cancer Res
; 20(1): 62, 2018 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29929548
12.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 398, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460777
13.
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
Oncologist
; 22(6): 648-654, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432226
14.
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
Int J Mol Sci
; 18(1)2017 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28054957
15.
A comparison of two fixation methods for femoral trochanteric fractures: a new generation intramedullary system vs sliding hip screw.
Clin Cases Miner Bone Metab
; 14(1): 40-47, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28740524
16.
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.
Lancet Oncol
; 16(16): 1700-10, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596672
17.
Preoperative carboplatin-paclitaxel-bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be study.
Ann Surg Oncol
; 22(9): 2881-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25572687
18.
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
J Natl Cancer Inst
; 116(1): 69-80, 2024 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676829
19.
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges.
Biomedicines
; 11(1)2023 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672617
20.
Personalized Systemic Therapies in Hereditary Cancer Syndromes.
Genes (Basel)
; 14(3)2023 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980956